Objective: Ischemia / reperfusion in the heart causes myocardial apoptosis and increase nitric oxide (NO) production. We have reported that myocardial apoptosis is related to activation of cell cycle regulatory proteins. However, the role of nitric oxide (NO) in ischemia / reperfusion-induced apoptosis is still unclear. This study was designated to elucidate novel apoptosis mechanisms induced by ischemia / reperfusion, especially the interaction between NO and cell cycle regulators. Methods and results: Neonatal cardiomyocytes from 1-or 2-day-old Wistar rats were subjected to 1-h ischemia and then to reperfusion. The rate of cardiomyocyte apoptosis increased significantly after 24 h of reperfusion as evaluated by TUNEL analysis. NO increased 1.8-fold after 15 min of reperfusion in cardiomyocytes. After 36 h of reperfusion, the apoptosis rate was greatly increased by the NO synthetase inhibitor, Nitro-L-arginine methyl ester (L-NAME), and decreased by the NO donor of S-nitroso-N-acetylpenicillamine (SNAP). Immunoblot analysis showed that the protein levels of cyclin A accumulated in a time-dependent manner in response to ischemia / reperfusion, and L-NAME inhibited this response. Ischemia / reperfusion also increased the activity of cyclin A-associated kinase, and the apoptosis was inhibited by infection of cip1 / waf1 dominant-negative cdk2 adenovirus. To clarify the involvement of p21 protein, which is the suppressor of cyclin A-associated kinase, we performed immunoblot analysis and examined its kinase activity. Treatment of cardiomyocytes with L-NAME suppressed the cip1 / waf1 p21 protein level and increased the cyclin A-associated kinase activity. The addition of SNAP showed inverse results. Conclusion: Our data indicates that NO released from cardiomyocytes under condition of ischemia / reperfusion exerts an antiapoptotic cip1 / waf1 effect by modulating cyclin A-associated kinase activity via p21 accumulation.
N itric oxide inhibits ischemia / reperfusion-induced myocardial apoptosis by modulating cyclin A-associated kinase activity a a , a a
This article is referred to in the Editorial by C. Pignatti and cytoprotection from ischemic injury [1] . NO is generated C. Stefanelli (pages 268-270) in this issue.
from L-arginine via NO synthetases and released from endothelial cells [2] as well as cardiomyocytes [3, 4] . Recent investigations showed that NO plays an important 1 . Introduction role in protecting myocardium from ischemia / reperfusion injury [5] [6] [7] [8] [9] . Nitric oxide (NO) is an endogenous regulatory molecule Although prompt reperfusion within a narrow time involved in a variety of physiological processes. These window has significantly reduced early mortality from include a broad range of activities such as regulation of acute myocardial infarction, post-infarction heart failure vessel tone, proliferation of smooth muscle cells, and resulting from ventricular remodeling is reaching epidemic proportions. During therapeutic intervention of acute myocardial infarction, the heart is still partially injured by reperfusion following ischemia. The ischemic episode 2 .2. Apoptotic assays causes cellular damage and cell loss attributable to apoptosis of cardiomyocytes [10] . If expansion of the apoptotic
The percentage of cells undergoing apoptosis was regions is to be prevented, the underlying mechanisms calculated as the ratio of apoptotic cells to total cells. have to be more thoroughly investigated.
Apoptotic cardiomyocytes detach from the substratum; The induction of apoptosis by various stimuli involves thus, the extent of apoptosis can be determined by counting mitochondria, death receptor, MAP/ JNK, and PI-3K /Akt floating and adherent cells with a cell counter (Sysmex cell [11] [12] [13] [14] . Moreover, apoptosis of proliferating cells incounter CDA-500, Long Grove, IL, USA) [27, 28] . For in volves cell cycle regulators [15] [16] [17] . The cardiomyocyte is situ TUNEL assay, floating cells were recovered from the terminally differentiated and irreversibly withdrawn from medium by centrifugation and pooled with the adherent the cell cycle. However, the cardiomyocytes express some cells collected by trypsinization. Cells were spun down cell cycle regulators. Recently, we and others showed that onto poly-L-lysine-coated slides, and TUNEL assays were certain apoptotic mechanisms modulate cell cycle regperformed with a commercially available kit for detecting ulators. For example, cyclin A-associated kinase activity is end-labeled DNA according to the manufacturer's instrucupregulated by an apoptotic mechanism; inhibition of tions (ApopTag, Oncor, Gaithersburg, MD, USA) and with cyclin A-associated kinase activity suppresses apoptosis anti-digoxigenin-rhodamine (Roche Diagnostics, In-[18 -20] .
dianapolis, IN, USA) [29] . All experiments were repeated Recent studies indicate that NO modulates the expreson at least three independent occasions with consistent sion of cell cycle regulatory proteins and cyclin-dependent results. kinase activities [21] [22] [23] . In the heart, NO formation is elevated after ischemia / reperfusion [24] , suggesting that 2 .3. Flowcytometric analysis of propidium iodide (PI)-NO may be involved in inhibition of myocardial apoptosis stained cells via modulation of cell cycle regulators.
In the present study, we have examined the interaction Apoptosis was assessed by quantifying hypodiploid between NO and cell-cycle regulatory proteins during nuclei undergoing DNA fragmentation via flowcytometric ischemia / reperfusion-induced apoptosis in neonatal rat analysis as described previously [30] . This method is based cultured cardiomyocytes.
on the observation that cells undergoing apoptosis when fixed in ethanol and stained with propidium iodide (PI) (Sigma) have a hypodiploid quantity of DNA and localize in a broad area below the G0 / G1 peak on a PI histogram.
. Methods
Ten thousand cells from each sample were counted with a FACSCalibur flowcytometer (Becton-Dickinson, San Jose, 2 .1. Cell culture and treatment CA, USA). Gating was performed to exclude very small debris with 2 log units weaker PI staining than that Neonatal cardiomyocytes from 1-or 2-day-old Wistar observed in G0 cells. The percentage of cells in different rats were isolated, subjected to Percoll gradient centrifugacell cycle stages was assessed with Cell Quest software tion, and cultured in vitro as described previously [25] .
(Becton-Dickinson). Cardiac fibroblasts were also prepared [26] . The cardiomyocytes were incubated in Eagle's minimum essential medium (MEM) (Sigma, St. Louis, MO, USA) sup-2 .4. Measurement of NO production plemented with 5% calf serum (CS) (JRH Biosciences, Lenexa, KS, USA) at 37 8C. After the growth medium was NO production after ischemia / reperfusion in carchanged, cells were exposed to ischemia / reperfusion condiomyocytes was measured with phenol red-free MEM dition. To obtain ischemia / reperfusion stimuli, cells were (Invitrogen, San Diego, CA, USA). NO was measured as exposed for 1 h to severe ischemic conditions in a nitrite [31] by Griess method according to the kit manufacPlexiglass chamber containing serum-free medium purged turer's protocol (Dojindo, Kumamoto, Japan). Briefly, after with a constant stream of water-saturated 95% N / 5% nitrate was reduced to nitrite, nitrite was mixed with the 2 CO . The cells were subsequently under normoxic conGriess' reagent (1% sulfanilamide, 0.1% naphthylethylene 2 ditions with 5% CS medium for reperfusion. Zero time diamine hydrochloride, and 2.5% phosphoric acid), and point was assigned the beginning of the reperfusion step.
absorbance of the reaction product was read at 540 nm All experiments were performed in accordance with the after a 10-min incubation. The recombinant adenoviruses of dominant-negative formed on 10 or 15% SDS-polyacrylamide gels. Sample cdk2 (dncdk2) were prepared as described previously [18] . Cardiomyocytes were infected by adenovirus at the 50 mmol / l DTT, 10 mg / ml aprotinin, 10 mg / ml leupeptin, multiplicity of infection (moi) and incubated for 1 h with and 10 mg / ml pepstatin A) and twice in kinase buffer (50 brief agitation every 15 min. After infection, the medium mmol / l Hepes (pH 8.0), 10 mmol / l MgCl , 2.5 mmol / l 2 was replaced by culture medium. Cdk2 activity was also EGTA, 10 mmol / l b-glycerophosphate, 1 mmol / l NaF, reduced by adding Roscovitine (100 mmol / l, Calbiochem, 0.1 mmol / l Na VO , 0.1 mmol / l PMSF, 1 mmol / l DTT, 3 4 La Jolla, CA, USA) to the medium. 10 mg / ml aprotinin, 10 mg / ml leupeptin, and 10 mg / ml pepstatin A), they were incubated in 25 ml of kinase assay 2 .7. In vitro histone H1 kinase assay solution (2 mg histone H1, 10 mmol / l ATP, 4 mCi [g-32 P]ATP in kinase buffer) for 20 min at 30 8C. The The cardiomyocytes were harvested at various time mixtures were boiled for 3 min, loaded onto 10% SDSpoints after ischemia / reperfusion. Whole-cell extracts (100 polyacrylamide gels, and exposed to X-ray film (Hyperfilm mg) were precleaned with protein A / G agarose beads MP, Life Science Amersham Biosciences, Buckingham-(sc-2003, Santa Cruz Biotechnology), and immunoshire, UK) after electrophoresis. precipitations were performed with anti-cdk2, anti-cyclin E, or anti-cyclin A polyclonal antibody overnight at 4 8C. Apoptosis in response to ischemia / reperfusion injury 3 .2. NO production and effect of NOS inhibitor in was investigated in primary neonatal rat cardiomyocytes.
.8. Statistical analysis
ischemia /reperfusion induced apoptosis The increased end-labeling of DNA in the ischemia / reperfusion-treated cardiomyocytes as detected by the NO concentration was measured in culture medium TUNEL method is shown in Fig. 1A . There were signifiunder ischemia / reperfusion conditions. NO production cant increases in the number of end-labeled carwas 1.8-fold higher in cardiomyocytes after 15 min of diomyocytes evaluated after 24 h of ischemia / reperfusion ischemia / reperfusion as compared to cardiomyocytes (control, 9.360.8% vs. ischemia / reperfusion, 20.662.7%).
under normoxic (control) conditions. Moreover, L-NAME A decreased number of viable cells among the ischemia /
(1 mmol / l) inhibited ischemia / reperfusion-induced NO reperfusion-treated cardiomyocytes as determined by cell production ( Fig. 2A, upper panel) . Unlike cardiomyocytes counts (control, 96.860.1% vs. ischemia / reperfusion, subjected to ischemia / reperfusion, there was no increase in 87.960.2%) is shown in Fig. 1B .
NO production of cardiomyocytes by readdition of serum in the medium under normoxic condition. Cardiomyocytes Thirty-six-hour ischemia / reperfusion-induced apoptosis as conditions, either under hypoxia with or without serum, evaluated by TUNEL assay was significantly higher in showed no increase in NO production. Furthermore, for cardiomyocytes treated with L-NAME than in cartesting whether NO was the effector for apoptosis in this diomyocytes receiving no L-NAME. On the other hand, the model, cardiomyocytes were exposed to L-NAME and apoptosis rate of cardiomyocytes treated with SNAP was SNAP (1 mmol / l) prior to 24 h of ischemia / reperfusion. significantly lower than in cardiomyocytes without SNAP under ischemia / reperfusion [ischemia / reperfusion only: fibroblasts. These results suggest that cyclin A expression 2361.4%, L-NAME (1) We then examined the effect of L-NAME on cyclin A protein expression under ischemia / reperfusion conditions.
.3. Change of cell-cycle regulator proteins in ischemia /
The accumulation of cyclin A protein by ischemia / reperfureperfusion-induced apoptosis and the effect of sion was facilitated by L-NAME. Also, we examined the endogenous NO in cardiomyocytes effect of SNAP on cyclin A protein expression under ischemia / reperfusion conditions. The accumulation of To determine whether the protein levels of cell-cycle cyclin A protein by ischemia / reperfusion was inhibited by regulators change in ischemia / reperfusion, we used im-SNAP (Fig. 4) . This suggests that cyclin A expression is munoblotting to examine several cell-cycle regulators, ie modulated by NO. cdks and cyclins. Under ischemia / reperfusion conditions, cyclin B, cyclin D, cyclin E, cdk2 and cdk4 protein did not 3 .4. Activation of cyclin A-associated kinase activity in change significantly, whereas the level of cyclin A gradualresponse to ischemia /reperfusion-induced apoptosis and ly increased in a time-dependent manner (Fig. 3A,C) . A the effect of endogenous NO comparison of cyclin A expression in cardiomyocytes and apoptosis-resistant cardiac fibroblast is shown in Fig. 3B .
The function of cyclin A or cyclin E is related to the The level of cyclin A protein did not change in cardiac kinase activity of cdk2 in complex with cyclin A or cyclin E. To confirm that cyclin A-associated or cdk2-associated cyclin A-associated kinase activity. The cyclin A-associkinase activity increases during ischemia / reperfusion, ated or cdk2-associated kinase activity induced by iscyclin A-associated, cyclin E-associated, and cdk2-associchemia / reperfusion was facilitated by the presence of ated complexes were immunoprecipitated by cyclin A, L-NAME. In contrast, these activities were inhibited by cyclin E, and cdk2 antibody, respectively, and assayed for SNAP (Fig. 5) . Thus, cyclin A-associated kinase activation kinase activity in vitro with histone H1 as substrate. We by ischemia / reperfusion is inhibited by NO. observed a 3.1-fold increase in the phosphorylation of cip1 / waf1 histone H1 in the complex immunoprecipitated by cyclin A 3 .5. Involvement of p21 activation and effect of and 1.8-fold increase in phosphorylation in the complex endogenous NO on ischemia /reperfusion-induced immunoprecipitated by cdk2. However, cyclin E-associapoptosis ated kinase activity was hardly changed (Fig. 5) . Thus, cyclin A-associated kinase activity is increased under
To understand the mechanism underlying the modulaischemia / reperfusion. tion of cyclin A / cdk2 activity in apoptotic cells, we cip1 / waf1
To examine whether the inhibition of cdk2 activity examined p21 protein, a cdk2 inhibitor known to could also inhibit the ischemia / reperfusion-induced apopplay a major role in the regulation of cdk2 activity. Under tosis, we infected the cells with dncdk2 adenovirus before the ischemia / reperfusion condition, the level of cip1 / waf1 ischemia / reperfusion or treatment with the chemical cdk2 p21 protein increased gradually in a time-depeninhibitor, Roscovitine. When cardiomyocyte were cultured dent manner as evaluated by immunoblot analysis cip1 / waf1 with cdk2 inhibitor, apoptosis was significantly reduced (5.660.5-fold in 24 h). p21 was significantly lower compared with ischemia / reperfusion condition by TUNEL in cardiomyocytes subjected to ischemia / reperfusion with method (Fig. 6) .
L-NAME than in cardiomyocytes subjected to ischemia / We next examined the effect of L-NAME and SNAP on reperfusion without L-NAME (Fig. 7) . Treatment of car- diomyocytes with SNAP in ischemia / reperfusion condition [1] . Nonetheless, the cytoprotective function of NO in cip1 / waf1 caused significant p21 protein accumulation as cardiomyocytes is still not precisely understood. In the compared to cardiomyocytes subjected to ischemia / represent study, we have shown that ischemia / reperfusion perfusion without SNAP. These results suggest that NO is induces apoptosis and increases the production of NO in cip1 / waf1
an upstream activator of p21 . cultured cardiomyocytes. NO acts to inhibit apoptosis mediated by the inhibition of cyclin A / cdk2 activity cip1 / waf1 associated with upregulation of cdk inhibitor p21 .
. Discussion
Our study is the first to show that NO plays a novel role in protecting cardiomyocytes from apoptosis by modulating It is well documented that NO is a regulator of cell cell cycle regulator proteins. physiology and plays an important role in cytoprotection Ischemia / reperfusion occurs in the ischemic region produced by angina pectoris or myocardial infarction and is often associated with arrhythmia, inflammation, and myocardial dysfunction. This in vitro experimental approach with cultured cardiomyocytes allows evaluation of the direct effect of ischemia / reperfusion on cardiomyocytes in the absence of additional effects induced by inflammatory cells. The present study showed that ischemia / reperfusion induced apoptosis in cardiomyocytes as evaluated by flowcytometric analysis, number of viable cells, and TUNEL assay. Moreover, endogenous NO synthesis in cardiomyocytes was increased under conditions of ischemia / reperfusion [24, 33] . Compared to that of the continuous hypoxic condition with or without serum, significantly increased NO production was detected in relation to ischemia / reperfusion stimuli. This suggests that ischemia / reperfusion is less damaging than ischemia alone. Apoptosis, which is sometimes occurred in uncontrolled condition of cell proliferation, implicates in a wide variety of physiological and pathological processes [27] . In recent to cardiomyocytes [17] . have shown that cyclin A protein and cyclin A-associated prevention of p21 protein degradation via an kinase activity increased concomitantly with apoptosis in ubiquitin-proteasome pathway [36] . In cardiomyocytes, the cip1 / waf1
cardiomyocytes after ischemia / reperfusion. Further, the ubiquitination of p21 might be activated in isintensities of apoptosis and cyclin A-associated kinase chemia / reperfusion. The effects of NO on apoptosis are activity were enhanced by L-NAME and were decreased by not only inhibitory as shown in this study but also SNAP, suggesting that myocardial apoptosis in response to stimulatory [37] . It is thought that a complex set of factors, ischemia / reperfusion is less damaging by endogenous NO, such as the type and timing of an apoptotic stimulus, the which modulates cyclin A-associated kinase activity (Fig. source of NO and the redox chemistry within cells, will 8). Several investigators reported that NO in proliferative determine the net effects of NO on apoptosis. These factors cells inhibits cell proliferation by suppressing cyclin Ato the cells may affect c-GMP response and / or S-nitrosylaassociated kinase activity through upregulation of tion for several apoptosis regulatory pathways [38] .
cip1 / waf1 p21 protein [21, 23, 34] . We and several other In conclusion, we showed that ischemia / reperfusion groups reported that caspase-3, an activator of apoptosis, promotes apoptosis in cardiomyocytes in vitro by moducip1 / waf1
truncates p21 cdk inhibitorand induces cdk activity lating the activity of novel cell cycle regulators and in apoptotic cells [15, 18, 35] . Thus, NO is likely to increase enhancement of endogenous NO production by ischemia / cip1 / waf1 the protein level of p21 , leading to suppression of reperfusion attenuates against apoptosis by inhibiting cdk cip1 / waf1 cdk activity. In the present study, we showed that activity via p21 . This might represent a physiologicip1 / waf1 p21 protein increased in ischemia / reperfusion-incal mechanism by which ischemia / reperfusion causes duced apoptosis in cardiomyocytes, and this change was cardiac apoptosis and cytoprotection simultaneously. The suppressed by L-NAME and was facilitated by SNAP, present study sheds light on the molecular mechanism suggesting that NO attenuates apoptosis through the upunderlying cardiac apoptosis and may point to a novel 
